Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
1 hedge funds and large institutions have $693 invested in Novo Integrated Sciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.
5.65% less ownership
Funds ownership: 5.72% → 0.07% (-5.7%)
94% less funds holding
Funds holding: 16 → 1 (-15)
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 16
100% less capital invested
Capital invested by funds: $306K → $693 (-$305K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$3.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$86.4K |
| 2 |
BlackRock
New York
|
-$81.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$41.6K |
| 4 |
HF
HRT Financial
New York
|
-$26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13.7K |
NVOS Hedge Fund Activity: Q4 2024 in Review
1 of the 7,611 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q4 2024, worth a combined $693 — down 100% from $306K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of NVOS and 1 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was ACT Advisors, opening a new position worth an estimated $3.08K. The largest seller was Vanguard Group, exiting entirely with an estimated $86.4K sold.
- 1 institutional investor held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q4 2024, down from 16 in Q3 2024.
- Funds reported $693 of Novo Integrated Sciences, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q4 2024 and 16 closed out, a net change of -15 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q4 2024 was ACT Advisors, an estimated $3.08K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $86.4K sold.
Based on aggregated 13F filings for Q4 2024.